The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Marks offered his resignation while citing Kennedy’s “misinformation and lies” and an “unprecedented assault on scientific ...
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...
Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for ...
As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to ...
The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were ...
In his resignation letter, Marks cited disagreement with HHS Secretary Robert F. Kennedy Jr., who he said pushed ...
Commissioner Marty Makary signed off on the plan to push out the agency’s top vaccine official, Peter Marks, in one of his ...